(Q37909132)

25 August 2017

1 reference

title

Supplemental studies for cardiovascular risk assessment in safety pharmacology: a critical overview (English)

1 reference

25 August 2017

1 reference

1 reference

5

0 references

author name string

Sandra Picard

1

1 reference

25 August 2017

Sonia Goineau

2

1 reference

25 August 2017

Philippe Guillaume

3

1 reference

25 August 2017

Joël Henry

4

1 reference

25 August 2017

René Rouet

6

1 reference

25 August 2017

publication date

1 December 2011

1 reference

Cardiovascular Toxicology

25 August 2017

published in

1 reference

25 August 2017

volume

11

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

285-307

1 reference

Torsades de pointes occurring in association with terfenadine use

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Origins, practices and future of safety pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Drug induced QT prolongation and torsades de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Drug-induced torsades de pointes and implications for drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Cellular basis of drug-induced torsades de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Drug-induced torsade de pointes: from molecular biology to bedside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome : direct evidence from intracellular recordings in the intact left ventricular wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Pharmacological approach to the treatment of long and short QT syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Evaluation of the rabbit Purkinje fibre assay as an in vitro tool for assessing the risk of drug-induced torsades de pointes in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Prediction of the risk of Torsade de Pointes using the model of isolated canine Purkinje fibres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Comparison of the effects of NS-21 and terodiline on the QTc interval in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de Pointes in models of acquired and congenital long QT syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Relevance of in vitro SCREENIT results for drug-induced QT interval prolongation in vivo: a database review and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

A rabbit Langendorff heart proarrhythmia model: predictive value for clinical identification of Torsades de Pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Defective protein trafficking in hERG-associated hereditary long QT syndrome (LQT2): molecular mechanisms and restoration of intracellular protein processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Protein trafficking abnormalities: a new mechanism in drug-induced long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Mechanisms of arsenic-induced prolongation of cardiac repolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Pentamidine-induced long QT syndrome and block of hERG trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Cardiac glycosides as novel inhibitors of human ether-a-go-go-related gene channel trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Coexistence of hERG current block and disruption of protein trafficking in ketoconazole-induced long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

The role of sodium channels in the effects of the cardiotonic compound DPI 201-106 on contractility and membrane potentials in isolated mammalian heart preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

The utility of hERG and repolarization assays in evaluating delayed cardiac repolarization: influence of multi-channel block

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Sertindole : a review of its use in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Rate dependence and regulation of action potential and calcium transient in a canine cardiac ventricular cell model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Computational physiology and the Physiome Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

A structural basis for drug-induced long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Comparative assessment of prurifloxacin, sparfloxacin, gatifloxacin and levofloxacin in the rabbit model of proarrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

QT and JT dispersion in the drug-induced long QT syndrome in anaesthetized rabbits is accurately detected by a three-lead surface ECG measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Nonselective I(Kr)-blockers do not induce torsades de pointes in the anesthetized rabbit during alpha1-adrenoceptor stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Halothane sensitizes the canine heart to pharmacological IKr blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

In vitro and in vivo models for testing arrhythmogenesis in drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Torsadegenic action of the antipsychotic drug sulpiride assessed using in vivo canine models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Electrophysiological, anatomical and histological remodeling of the heart to AV block enhances susceptibility to arrhythmogenic effects of QT-prolonging drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Cardiovascular profile of the canine torsades de pointes arrhythmia model assessed by echocardiographic and haemodynamic methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Comparison of the in vivo electrophysiological and proarrhythmic effects of amiodarone with those of a selective class III drug, sematilide, using a canine chronic atrioventricular block model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Effects of 5-HT(4) receptor agonists, cisapride and mosapride citrate on electrocardiogram in anaesthetized rats and guinea-pigs and conscious cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: pharmacokinetic/pharmacodynamic model incorporating a site of adverse effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

QT prolongation in anaesthetized guinea-pigs: an experimental approach for preliminary screening of torsadogenicity of drugs and drug candidates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Cardiovascular parameters in anaesthetized guinea pigs: a safety pharmacology screening model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

The novel class III antiarrhythmics NE-10064 and NE-10133 inhibit IsK channels expressed in Xenopus oocytes and IKs in guinea pig cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Effects of alpha-adrenoceptor agonists and antagonists on ouabain-induced arrhythmias and cardiac arrest in guinea-pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

The in-vivo cardiovascular effects of a putative class III anti-arrhythmic drug, AM 92016.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Differentiation of arrhythmia risk of the antibacterials moxifloxacin, erythromycin, and telithromycin based on analysis of monophasic action potential duration alternans and cardiac instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Differential effect of HERG blocking agents on cardiac electrical alternans in the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Electrical alternans and hemodynamics in the anesthetized guinea pig can discriminate the cardiac safety of antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

QT and RR Intervals in Conscious and Anesthetized Guinea Pigs with Highly Varying RR Intervals and Given QTc-Lengthening Test Articles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Chronic monitoring of cardiovascular function in the conscious guinea pig using radio-telemetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

The role of ketoconazole in the QTc interval prolonging effects of H1-antihistamines in a guinea-pig model of arrhythmogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Practical application of guinea pig telemetry system for QT evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Measurements of blood pressure and electrocardiogram in conscious freely moving guineapigs: a model for screening QT interval prolongation effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

QT interval variables from 24 hour electrocardiography and the two year risk of sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Short QT Syndrome: a familial cause of sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Short QT syndrome: clinical findings and diagnostic-therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Sudden cardiac arrest associated with early repolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

KATP channels and 'border zone' arrhythmias: role of the repolarization dispersion between normal and ischaemic ventricular regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Amplified transmural dispersion of repolarization as the basis for arrhythmogenesis in a canine ventricular-wedge model of short-QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Cellular basis for atrial fibrillation in an experimental model of short QT1: implications for a pharmacological approach to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Rapid and stable re-entry within the pulmonary vein as a mechanism initiating paroxysmal atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Late-phase 3 EAD. A unique mechanism contributing to initiation of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Cibenzoline induced Brugada ECG pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Propranolol intoxication revealing a Brugada syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Transient ST segment elevation in right precordial leads induced by psychotropic drugs: relationship to the Brugada syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Cellular basis for the electrocardiographic J wave

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Role of sodium and calcium channel block in unmasking the Brugada syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Role of wavelength adaptation in the initiation, maintenance, and pharmacologic suppression of reentry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Enhancement by ischemia of the risk of cardiac disorders, especially fibrillation, in regional anesthesia with bupivacaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Proarrhythmic and antiarrhythmic effects of bupivacaine in an in vitro model of myocardial ischemia and reperfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Density and kinetics of I(Kr) and I(Ks) in guinea pig and rabbit ventricular myocytes explain different efficacy of I(Ks) blockade at high heart rate in guinea pig and rabbit: implications for arrhythmogenesis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Assessing the proarrhythmic potential of drugs: current status of models and surrogate parameters of torsades de pointes arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Cardiovascular effects of noncardiovascular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Cardiovascular effects of high dose venlafaxine XL in patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Phenylpropanolamine and the risk of hemorrhagic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Cardiovascular action of a cardioselective Ca(2+)channel blocker AH-1058 in conscious dogs assessed by telemetry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Assessment of the pharmacological effects of inotropic drugs on left ventricular pressure and contractility: an evaluation of the QA interval as an indirect indicator of cardiac inotropism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Peripheral versus central muscarinic effects on blood pressure, cardiac contractility, heart rate, and body temperature in the rat monitored by radiotelemetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

QA interval as an indirect measure of cardiac contractility in the conscious telemeterised rat: model optimisation and evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Blood cardiac troponin in toxic myocardial injury: archetype of a translational safety biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

A translational approach to detecting drug-induced cardiac injury with cardiac troponins: consensus and recommendations from the Cardiac Troponins Biomarker Working Group of the Health and Environmental Sciences Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Mechanisms of FK 506-induced hypertension in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Effects of FK506 in rat and human resistance arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Acute and chronic cardiac and regional haemodynamic effects of the novel bradycardic agent, S16257, in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Prognosis of diastolic and systolic orthostatic hypotension in older persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Drug-Induced Orthostatic Hypotension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Treatment of benign prostatic hyperplasia in patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Drug-induced orthostatic hypotension in the elderly: avoiding its onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

A rat model for predicting orthostatic hypotension during acute and chronic antihypertensive drug therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Vascular alpha1-adrenoceptor subtype selectivity and alpha1-blocker-induced orthostatic hypotension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Comparative study of TA-606, a novel angiotensin II receptor antagonist, with losartan in terms of species difference and orthostatic hypotension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Evidence for a functional cardiac interaction between losartan and angiotensin-(1-7) receptors revealed by orthostatic tilting test in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Central mechanisms underlying short- and long-term regulation of the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Differential effects of anesthetics on sympathetic nerve activity and arterial baroreceptor reflex in chronically instrumented rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Cardiovascular reactivity after blockade of angiotensin AT1 receptors in the experimental model of tilting test in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Effects of yohimbine, an alpha 2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Valvular heart disease associated with fenfluramine-phentermine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Drug-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Investigation of relation between use of oral contraceptives and thromboembolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Primary pulmonary hypertension associated with the use of fenfluramine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

A refined radio-telemetry technique to monitor right ventricle or pulmonary artery pressures in rats: a useful tool in pulmonary hypertension research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

Long-term serotonin administration induces heart valve disease in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-011-9133-Z

10.1007/S12012-011-9133-Z

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference